NCT04630912

Brief Summary

Introduction: People with dementia have a high prevalence of psychological distress but are under-served with evidence-based psychological interventions. To promote choice and improve clinical outcomes, there is a necessity to test different psychological intervention options for this population. Purpose: To investigate the effectiveness and acceptability of Acceptance and Commitment Therapy (ACT) for people with dementia, considering carer-supported, remote delivery and necessary therapy adaptations. Methods: A hermeneutic single case efficacy design (HSCED) series was used to analyse therapy process and change for three clients with dementia and psychological distress. Quantitative and qualitative data was collated ('rich case records') and analysed by three independent psychotherapy experts ('judges') who determined the outcome for each client. Results: Over the course of therapy, it was concluded that one client with dementia made positive changes, specifically reliable reductions in psychological distress, which were largely attributable to Acceptance and Commitment Therapy (ACT). Two clients remained unchanged. Discussion/Conclusion: Where change was achieved, the ACT-specific processes of values, committed action and acceptance, in combination with non-specific therapy factors including a strong client-carer relationship, existing client interests and individualised therapy adaptations, were facilitative of change. Hence, ACT may be feasible and effective by helping carers to better meet the needs of their loved ones with dementia. Future research to optimise ACT delivery in this population may be beneficial. Furthermore, the assessment of carer factors (e.g., their psychological flexibility, the client-carer relationship) may strengthen the evidence-base for systemic ACT-use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 16, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

January 20, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 14, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2022

Completed
Last Updated

August 19, 2022

Status Verified

August 1, 2022

Enrollment Period

9 months

First QC Date

November 2, 2020

Last Update Submit

August 16, 2022

Conditions

Keywords

DementiaPsychological distressPsychological therapyACTAcceptabilityHSCED

Outcome Measures

Primary Outcomes (2)

  • Change in anxiety

    Generalised anxiety disorder questionnaire (GAD-7), scored 0-21, where higher scores indicate a greater severity of anxiety.

    Through study completion, up to 24 weeks

  • Change in depression

    Patient health questionnaire (PHQ-9), scored 0-27, where higher scores indicate a greater severity of depression.

    Through study completion, up to 24 weeks

Secondary Outcomes (4)

  • Change in psychological flexibility

    Through study completion, up to 24 weeks

  • Change in wellbeing

    Through study completion, up to 24 weeks

  • Change in client problems

    Through study completion, up to 24 weeks

  • Change in therapeutic alliance

    Through study completion, up to 12 weeks

Study Arms (1)

Acceptance and Commitment Therapy

EXPERIMENTAL

12 weekly, 90 minute ACT sessions with person with dementia (with a review at week 6)

Other: Acceptance and Commitment Therapy

Interventions

There is no specific protocol for ACT with dementia, therefore a published ACT protocol, 'Better Living with Illness' (Brassington et al., 2016), will be used flexibly to guide the intervention.

Acceptance and Commitment Therapy

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Participants were included in the study if they had:
  • A clinical diagnosis of dementia (any type)
  • A clinically significant level of psychological distress (a score of ≥8 on the GAD-7 and ≥10 on the PHQ-9).
  • Ability to give informed consent
  • Participants were included in the study if they:
  • Cared for someone with a clinical diagnosis of dementia (any type)
  • Were paid or unpaid and regularly supported them with activities of daily living
  • Aged 18+ (no maximum age limit)
  • Able to give informed consent

You may not qualify if:

  • Participants were excluded if they:
  • Were already receiving psychotherapy
  • Had insufficient English or language abilities to engage in therapy
  • Were unable to consent to and/or engage in therapy
  • Participants were excluded if they:
  • Had insufficient English or language abilities to support the person with dementia or engage in study/Change Interviews
  • Were unable to consent to and/or engage in study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Community Mental Health Team for Older People

Newark, Nottinghamshire, United Kingdom

Location

MeSH Terms

Conditions

Dementia

Interventions

Acceptance and Commitment Therapy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Danielle De Boos, Dr

    University of Nottingham

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Hermeneutic single case efficacy design (HSCED) series
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2020

First Posted

November 16, 2020

Study Start

January 20, 2021

Primary Completion

October 14, 2021

Study Completion

July 22, 2022

Last Updated

August 19, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will share

The study data was written up as part of the student Doctoral Thesis and will be submitted in partial fulfilment of the requirements for the Trent Doctorate in Clinical Psychology (DClinPsy) in February 2022. Participants chose a pseudonym for themselves to be used in publications (e.g. electronic documents, written notes and transcripts) to prevent identification and references to personal information (e.g. other people's names, locations) were altered.

Shared Documents
CSR
Time Frame
July 2022

Locations